captopril has been researched along with Pseudomonas Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlsen, TJ; Christopeit, T; Helland, R; Leiros, HK | 1 |
Akaike, T; Maeda, H; Maruo, K; Sakata, Y | 1 |
Domínguez Alvarez, LM; Fernández Seara, J; Pereira Jorge, JA; Rodríguez Canal, A; Rodríguez Pérez, R | 1 |
3 other study(ies) available for captopril and Pseudomonas Infections
Article | Year |
---|---|
Discovery of Novel Inhibitor Scaffolds against the Metallo-β-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Crystallography, X-Ray; Drug Design; Drug Resistance, Bacterial; Humans; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Small Molecule Libraries; Surface Plasmon Resonance | 2015 |
Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin.
Topics: alpha-Macroglobulins; Animals; Biotransformation; Bradykinin; Captopril; Endopeptidases; Leukocyte Elastase; Macroglobulins; Mice; Pancreatic Elastase; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Vibrio Infections | 1993 |
[Agranulocytosis induced by captopril after 4 months of treatment].
Topics: Agranulocytosis; Captopril; Diabetes Mellitus, Type 1; Disease Susceptibility; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Pneumonia; Pseudomonas Infections | 1991 |